Skip to main content
. 2018 Jan 3;9(11):9766–9775. doi: 10.18632/oncotarget.23919

Table 2. Multivariate analysis for PFS and OS in systemic T-cell NHL patients.

Factors Multivariate for PFS Multivariate for OS
HR (95% Cl) P value HR (95% Cl) P value HR (95% Cl) P value HR (95% Cl) P value
Proportion of involved areas (%)
 0-50 1.00 1.00
 51-100 0.53 (0.27–1.03) 0.0627 0.55 (0.27–1.12) 0.1011
Pattern of expression
 Negative or Stromal only 1.00 1.00
 Vascular plus Stromal 0.52 (0.25–1.08) 0.0785 0.41 (0.19–0.88) 0.0228
Age
 ≤ 60 1.00 1.00 1.00 1.00
 > 60 1.56 (0.70–3.51) 0.2800 1.31 (0.58–2.94) 0.5158 1.92 (0.83–4.42) 0.1256 1.59 (0.71–3.54) 0.2591
Gender
 Female 1.00 1.00 1.00 1.00
 Male 1.17 (0.59–2.31) 0.6506 1.33 (0.66–2.66) 0.4218 1.54 (0.75–3.14) 0.2366 1.81 (0.87–3.80) 0.1144
IPI
Low 1.00 1.00 1.00 1.00
Interm-Low 1.71 (0.61–4.81) 0.3121 1.88 (0.68–5.22) 0.226 1.96 (0.66–5.79) 0.2239 2.23 (0.77–6.47) 0.1387
Interm-High 1.81 (0.67–4.92) 0.2446 2.39 (0.91–6.29) 0.0774 1.82 (0.61–5.42) 0.2855 2.36 (0.83–6.75) 0.1089
High 4.10 (1.57–10.68) 0.0039 5.99 (2.12–16.92) 0.0007 5.10 (1.92–13.54) 0.0011 8.41 (2.93–24.14) <.0001

Legend: NHL: non-Hodgkin lymphoma; PFS: progression free survival; OS: overall survival.